Stay updated on Immune-Target Combo in 2L+ Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Immune-Target Combo in 2L+ Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immune-Target Combo in 2L+ Renal Cell Carcinoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Page now includes a government funding status notice and upgrades the version from v3.0.2 to v3.2.0, signaling updated operational status information and a software version change.
    Difference
    2%
    Check dated 2025-10-02T01:20:55.000Z thumbnail image
  4. Check
    18 days ago
    Change Detected
    Summary
    Version bumped from v3.0.2 to v3.1.0; no other substantive content changes detected.
    Difference
    0.0%
    Check dated 2025-09-30T12:18:56.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Version updated to v3.0.2 and the 'Back to Top' element was removed; no substantive changes to core content, pricing, stock, or schedules.
    Difference
    0.1%
    Check dated 2025-09-16T04:30:29.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.1%
    Check dated 2025-09-09T00:17:15.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of new facility names and locations across various regions, as well as updated drug information for Pembrolizumab, Belzutifan, and Lenvatinib. Notably, some previously listed locations and drug information have been removed.
    Difference
    11%
    Check dated 2025-09-01T20:31:57.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.0%
    Check dated 2025-08-18T13:23:42.000Z thumbnail image

Stay in the know with updates to Immune-Target Combo in 2L+ Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immune-Target Combo in 2L+ Renal Cell Carcinoma Clinical Trial page.